Lacosamide
NDC 10135-800, Lacosamide, tablet, film coated, from Marlex Pharmaceuticals, Inc.
- Product NDC
- 10135-800
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218014
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/10135-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE100 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-800-60 | 10135080060 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (10135-800-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0a273024-c2d2-4fae-90c3-b2f38a323f24
Use it
Look up 10135-800 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-800. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.